Orotic acid.
D000493:Allopurinol / Q000009:adverse effects; D000752:Anemia, Pernicious / Q000188:drug therapy; D000818:Animals; D001380:Azauridine / Q000009:adverse effects; D002262:Carboxy-Lyases; D005234:Fatty Liver / Q000139:chemically induced; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D008659:Metabolic Diseases / Q000139:chemically induced / Q000188:drug therapy; D008661:Metabolism, Inborn Errors / Q000201:enzymology; D008892:Milk / Q000032:analysis; D009203:Myocardial Infarction / Q000188:drug therapy; D009954:Ornithine Carbamoyltransferase; D009963:Orotic Acid / Q000032:analysis / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity / Q000652:urine; D010430:Pentosyltransferases; D011247:Pregnancy; D014527:Uric Acid / Q000097:blood
D008055:Lipids; D014527:Uric Acid; D009963:Orotic Acid; D000493:Allopurinol; D001380:Azauridine; D009954:Ornithine Carbamoyltransferase; D010430:Pentosyltransferases; D002262:Carboxy-Lyases